Olink®Part of Thermo Fisher Scientific
Capture true biological insights with proven specificity. At any scale.
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join the growing global community and consortia of Olink users to empower your biomarker discovery.
Over 1,800 and growing rapidly – covering all major disease areas
Help shape the future of health research with Olink’s cutting-edge technology
Filters
Cell, 2020The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19
Consiglio C., Cotugno N., Sardh F. et al.
Olink Target 96
The Journal of Clinical Endocrinology & Metabolism, 2020Biomarkers of Inflammation and Glomerular Filtration Rate in Individuals with Recent-Onset Type 1 and Type 2 Diabetes
Maalmi H., Herder C., Strassburger K. et al.
Translational Vision Science & Technology, 2020Comparative Analysis of Multiplex Platforms for Detecting Vitreous Biomarkers in Diabetic Retinopathy
Lamy R., Farber-Katz S., Vives F. et al.
Rheumatology, 2020Interferon activation status underlies higher antibody response to viral antigens in patients with systemic lupus erythematosus receiving no or light treatment
Björk A., Da Silva Rodrigues R., Richardsdotter Andersson E. et al.
Circulation, 2020Colchicine Attenuates Inflammation Beyond the Inflammasome in Chronic Coronary Artery Disease
Opstal T., Hoogeveen R., Fiolet A. et al.
Frontiers in Public Health, 2020Exposure to Mild Steel Welding and Changes in Serum Proteins With Putative Neurological Function—A Longitudinal Study
Gliga A., Taj T., Wahlberg K. et al.
Nature Reviews Genetics, 2020Genetics meets proteomics: perspectives for large population-based studies
Suhre K., McCarthy M., Schwenk J.
Cancers, 2020Preoperative Fasting and General Anaesthesia Alter the Plasma Proteome
Gyllensten U., Bosdotter Enroth S., Stålberg K. et al.
Critical Care Explorations, 2020Novel Outcome Biomarkers Identified With Targeted Proteomic Analyses of Plasma From Critically Ill Coronavirus Disease 2019 Patients
Fraser D., Cepinskas G., Patterson E. et al.
Nature Medicine, 2020An inflammatory cytokine signature predicts COVID-19 severity and survival
Del Valle D., Kim-Schulze S., Huang H. et al.
Environmental Research, 2020Association between prenatal immune phenotyping and cord blood leukocyte telomere length in the PRISM pregnancy cohort
Colicino E., Cowell W., Bozack A. et al.
Science Immunology, 2020Natural killer cell immunotypes related to COVID-19 disease severity
Maucourant C., Filipovic I., Ponzetta A. et al.
Proceedings of the National Academy of Sciences, 2020Multiomic blood correlates of genetic risk identify presymptomatic disease alterations
Wainberg M., Magis A., Earls J. et al.
Clinical Cancer Research, 2020Integration of Antiangiogenic Therapy with Cisplatin and Gemcitabine Chemotherapy in Patients with Nasopharyngeal Carcinoma
Chong W., Lim C., Sinha A. et al.
Frontiers in Immunology, 2020Tape-Strip Proteomic Profiling of Atopic Dermatitis on Dupilumab Identifies Minimally Invasive Biomarkers
He H., Olesen C., Pavel A. et al.
Clinical Research in Cardiology, 2020Multi-proteomic approach to predict specific cardiovascular events in patients with diabetes and myocardial infarction: findings from the EXAMINE trial
Ferreira J., Sharma A., Mehta C. et al.
European Heart Journal, 2020Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation
Wallentin L., Lindbäck J., Eriksson N. et al.
Science, 2020Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans
Arunachalam P., Wimmers F., Mok C. et al.
GSC Biological and Pharmaceutical Sciences, 2020Susceptibility of men to SARS-CoV-2 may be caused by sex differences in ACE2 expression
Cell Reports Medicine, 2020Systems-Level Immunomonitoring from Acute to Recovery Phase of Severe COVID-19
Rodriguez L., Pekkarinen P., Lakshmikanth T. et al.
1945 publications
Items per page
1481-1500 of 1945 publications